Related Experiment Video
Updated: Dec 11, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
[Macular edema: Understand mechanisms to develop treatments]
Francine Behar-Cohen1, Min Zhao2, Emmanuelle Gelize2
1Centre de Recherche des Cordeliers, Inserm, UMRS1138, équipe 17, Université de Paris, Université Sorbonne Paris Cité, 15 rue de l'École de Médecine, 75006 Paris, France - Ophtalmopole, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université de Paris, 24 rue du Faubourg Saint-Jacques, 75014 Paris, France.
Abstract:
Macular edema is an increase in volume of the central area of the retina, responsible for visual acuity. Visual symptoms handicap the lives of millions of patients with macular edema secondary to chronic and sometimes acute retinal disease. Proteins that neutralize the vascular endothelial growth factor (VEGF) pathway or glucocorticoids, at the cost of repeated intraocular injections over years, limit visual symptoms. A better understanding of why and how edema forms and how therapeutic molecules exert an anti-edematous effect will help prevent this disabling and blinding retinal complication from occurring.
More Related Videos
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
10:10Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Nephrotic Syndrome III : Nursing Management
Glaucoma: Overview
Nephrotic Syndrome II : Assessment and Medical Management